Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Merck Millipore Introduces Amicon® Pro Purification System for Protein Purification

Published: Tuesday, April 09, 2013
Last Updated: Tuesday, April 09, 2013
Bookmark and Share
Combines the bind, wash, elute, buffer exchange and concentration steps into one device.

Merck Millipore has introduced Amicon® Pro Purification System for Protein Purification. This centrifugal device streamlines the affinity purification workflow and minimizes protein loss.

Users experience consistent, accurate sample preparation, resulting in more reliable recovery, uncompromised purity and easier data generation.

The Amicon® Pro purification system combines the bind, wash, elute, buffer exchange and concentration steps into one device, eliminating risky sample transfers and reducing hands-on time.

The device integrates affinity-based spin column purification with downstream sample concentration and buffer exchange.

Featuring a large reservoir that accommodates a range of sample volumes, the Amicon® Pro system reduces the need for multiple washing and elution steps.

"Traditional protein purification is a long process with many steps, dilutions and multiple tubes, often resulting in protein degradation and loss," notes John Sweeney, Head of the Bioscience business unit, Merck Millipore.

Sweeney continued, "The Amicon® Pro affinity purification system is a game-changing improvement in general affinity purification and also transforms applications such as depletion of abundant proteins, protein enrichment and clean-up of antibody labeling reactions."

In addition to fast and efficient affinity purification, the Amicon® device supports single-spin diafiltration and depletion with concentration in a single step.

The Amicon® Pro purification system also provides the ideal processing tool for small-batch antibody labeling.

Antibody labeling and high-yield purification can be completed in as little as one hour.

Antibody cleanup routinely involves the removal of BSA/carrier, labeling, removal of unbound label, dialysis, and final concentration.

Using standard dialysis, the procedure can take up to three days to complete. With the all-in-one format of the Amicon® Pro device, loss due to sample transfers is eliminated and recovery can be significantly improved.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck Millipore Announces Agreement with Precision Biologics
Merck Millipore services include design and development of cost-effective process to deliver high yield and productivity.
Thursday, February 05, 2015
Merck Millipore Partners with Gyros
Partnership to develop, manufacture and commercialize kits on the Gyrolab™ immunoassay platform.
Tuesday, July 16, 2013
Merck Millipore Announces Partnership with NIH Consortium
Adds more than 140 peer-validated neuroscience-specific monoclonal antibodies to portfolio.
Tuesday, October 16, 2012
Scientific News
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
Developing Drug Resistance may be a Matter of Diversity for Tuberculosis
Researchers have probed the bacteria that causes tuberculosis, Mycobacterium tuberculosis, to learn more about how individual bacterial cells change and adapt while in the human body.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
Some Gut Microbes May Be Keystones of Health
University of Oregon scientists have found that strength in numbers doesn’t hold true for microbes in the intestines. A minority population of the right type might hold the key to regulating good health.
Essential Component of Antiviral Defense Identified
Infectious disease researchers at the University of Georgia have identified a signaling protein critical for host defense against influenza infection.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Is Allergy the Price We Pay for Our Immunity to Parasites?
New findings help demonstrate the evolutionary basis for allergy.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
Mucus – the First Line of Defence
Researchers reveal the important role of mucus in building a good defence against invaders.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos